Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
CORONA Stock Analysis
Views
Red Flags
Positive
High ROE
High operating margin
Moderate revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity
Company's earnings are of high quality
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
CORONA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
CORONA Bulk, Block & Insider Trades
CORONA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Corona Remedies Limited is an India-based pharmaceutical formulation company. The Company is engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabetes, pain management, urology and other/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (... Read More
Key personnel
Dr. Kirtikumar Laxmidas MehtaD
Non-Executive Chairman of the Board
Mr. Niravkumar Kirtikumar MehtaD
Chief Executive Officer, Managing Director, Whole Time Director
Mr. Bhavin Nareshbhai Bhagat
Chief Financial Officer
Ms. Chetna Prabhatkumar Dharajiya
Company Secretary, Compliance Officer
Mr. Ankur Kirtikumar MehtaD
Joint Managing Director, Whole Time Director
Mr. Viral Bhupendrabhai SitwalaD
Whole Time Director
Mr. Shirish Gundopant BelapureD
Independent Director
Mr. Ameetkumar Hiranyakumar DesaiD
Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of CORONA Remedies Ltd.?
The current share price of CORONA Remedies Ltd. is ₹ 1,427.85 as of 09 Jan 2026.
What is the PE ratio of CORONA Remedies Ltd.?
The Price-to-Earnings (PE) ratio of CORONA Remedies Ltd. is 49.89 as of the latest financial data.
What is the ROE and ROCE of CORONA Remedies Ltd.?
CORONA Remedies Ltd. has a Return on Equity (ROE) of 27.50% and a Return on Capital Employed (ROCE) of 30.59% as per the latest financial reports.
What is the market cap of CORONA Remedies Ltd.?
The market capitalization of CORONA Remedies Ltd. stands at ₹ 8,732.73 Cr.
What is the dividend yield of CORONA Remedies Ltd.?
The dividend yield of CORONA Remedies Ltd. is 0.00% based on the current market price.
What is the RSI of CORONA Remedies Ltd.?
The Relative Strength Index (RSI) of CORONA Remedies Ltd. is 52.34.
What is the FII and DII holding in CORONA Remedies Ltd.?
Foreign Institutional Investors (FII) hold 1.04% and Domestic Institutional Investors (DII) hold 3.44% of CORONA Remedies Ltd. shares.
What sector does CORONA Remedies Ltd. belong to?
CORONA Remedies Ltd. operates in the Healthcare sector.
What is the beta of CORONA Remedies Ltd. stock?
The beta of CORONA Remedies Ltd. stock is -, indicating its volatility relative to the broader market.
